Protagonist Therapeutics (PTGX) Other Working Capital Changes (2015 - 2026)

Protagonist Therapeutics has reported Other Working Capital Changes for 10 years, with the latest figure at -$547000.0 in Q1 2026.

• Quarterly Other Working Capital Changes rose 90.05% year-over-year to -$547000.0 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$16.1 million (up 19.56% YoY) and the FY2025 annual result came in at -$21.0 million, down 168.76% from the prior year.
• Other Working Capital Changes rose to -$547000.0 in Q1 2026 per PTGX's latest filing, from -$7.4 million in the prior quarter.
• Over five years, Other Working Capital Changes peaked at $2.0 million in Q2 2024 and troughed at -$3.3 million in Q4 2022.
• A 5-year average of $149352.9 and a median of $365000.0 in 2025 frame the typical range for Other Working Capital Changes.
• The sharpest annual moves came in 2024 and 2025: Other Working Capital Changes surged 23120.1% in 2024, then plunged 112.2% in 2025.
• Over 5 years, Other Working Capital Changes stood at -$768000.0 in 2022, then jumped by 125.26% to $194000.0 in 2023, then sank by 3006.19% to -$5.6 million in 2024, then tumbled by 31.93% to -$7.4 million in 2025, then soared by 92.65% to -$547000.0 in 2026.
• According to Business Quant data, Other Working Capital Changes over the past three periods registered -$547000.0, -$7.4 million, and -$3.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.